Role of CXCR2 on the immune modulating activity of α-iso-cubebenol a natural compound isolated from the Schisandra chinensis fruit

Biochemical and Biophysical Research Communications

Volumn 431, Issue 3, 2013, Pages 433-436

  Jung, Young Su ^a,b   Lee, Sung Kyun ^a,b   Ok, Chang Youp ^a   Cho, Eun Jung ^a,b   Park, Joon Seong ^c   Choi, Young Whan ^d   Bae, Yoe Sik ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Dong A University   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Pusan National University   (South Korea)

Author keywords

Iso cubebenol; CXCR2; Inflammation; Sepsis

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; ALPHA ISO CUBEBENOL; CALCIUM; CHEMOKINE RECEPTOR CXCR2; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; FRUIT; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SCHISANDRA CHINENSIS; SEPSIS;

ANIMALS; CALCIUM; CELL DEGRANULATION; CHEMOTAXIS; HUMANS; IMMUNOLOGIC FACTORS; MALE; MICE; MICE, INBRED ICR; NEUTROPHILS; PHENYLUREA COMPOUNDS; RECEPTORS, INTERLEUKIN-8B; SCHISANDRA; SEPSIS; SESQUITERPENES;

SCHISANDRA CHINENSIS;

EID: 84873717187     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.152     Document Type: Article

References (28)

1. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
2. Kumar G., Kumar N., Taneja A., Kaleekal T., Tarima S., McGinley E., Jimenez E., Mohan A., Khan R.A., Whittle J., Jacobs E., Nanchal R. Milwaukee initiative in critical care outcomes research group of investigators. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 2011, 140:1223-1231.
3. Chapman R.W., Phillips J.E., Hipkin R.W., Curran A.K., Lundell D., Fine J.S. CXCR2 antagonists for the treatment of pulmonary disease. Pharmacol. Ther. 2009, 121:55-68.
4. Wu L., Ruffing N., Shi X., Newman W., Soler D., Mackay C.R., Qin S. Discrete steps in binding and signaling of interleukin-8 with its receptor. J. Biol. Chem. 1996, 271:31202-31209.
5. Boisvert W.A., Curtiss L.K., Terkeltaub R.A. Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol. Res. 2000, 21:129-137.
6. Baggiolini M., Walz A., Kunkel S.L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 1989, 84:1045-1049.
7. Mehrad B., Strieter R.M., Moore T.A., Tsai W.C., Lira S.A., Standiford T.J. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J. Immunol. 1999, 163:6086-6094.
8. Weathington N.M., van Houwelingen A.H., Noerager B.D., Jackson P.L., Kraneveld A.D., Galin F.S., Folkerts G., Nijkamp F.P., Blalock J.E. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 2006, 12:317-323.
9. Kim S.D., Lee H.Y., Shim J.W., Kim H.J., Yoo Y.H., Park J.S., Baek S.H., Zabel B.A., Bae Y.S. Activation of CXCR2 by extracellular matrix degradation product acetylated Pro-Gly-Pro has therapeutic effects against sepsis. Am. J. Respir. Crit. Care Med. 2011, 184:243-251.
10. Lee Y.J., Park S.Y., Kim S.G., Park D.J., Kang J.S., Lee S.J., Yoon S., Kim Y.H., Bae Y.S., Choi Y.W. Identification of a novel compound that inhibits iNOS and COX-2 expression in LPS-stimulated macrophages from Schisandra chinensis. Biochem. Biophys. Res. Commun. 2010, 391:1687-1692.
11. Lee S.K., Kim S.D., Kook M., Lee H.Y., Park J.S., Park Y.H., Kang J.S., Jung W.J., Choi Y.W., Bae Y.S. Therapeutic effects of α-iso-cubebenol, a natural compound isolated from the Schisandra chinensis fruit, against sepsis. Biochem. Biophys. Res. Commun. 2012, 427:547-552.
12. Bae Y.S., Bae H., Kim Y., Lee T.G., Suh P.G., Ryu S.H. Identification of novel chemoattractant peptides for human leukocytes. Blood 2001, 97:2854-2862.
13. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
14. Bae Y.S., Lee H.Y., Jo E.J., Kim J.I., Kang H.K., Ye R.D., Kwak J.Y., Ryu S.H. Differential activation of formyl peptide receptor-like 1 by peptide ligands. J. Immunol. 2003, 171:6807-6813.
15. Bae Y.S., Song J.Y., Kim Y., He R., Ye R.D., Kwak J.Y., Suh P.G., Ryu S.H. Differential activation of formyl peptide receptor signaling by peptide ligands. Mol. Pharmacol. 2003, 64:841-847.
16. Bae Y.S., Lee H.Y., Jo E.J., Kim J.I., Kang H.K., Ye R.D., Kwak J.Y., Ryu S.H. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 2004, 173:607-614.
17. Kim S.D., Kim Y.K., Lee H.Y., Kim Y.S., Jeon S.G., Baek S.H., Song D.K., Ryu S.H., Bae Y.S. The agonists of formyl peptide receptors prevent development of severe sepsis after microbial infection. J. Immunol. 2010, 185:4302-4310.
18. Bae Y.S., Ju S.A., Kim J.Y., Seo J.K., Baek S.H., Kwak J.Y., Kim B.S., Suh P.G., Ryu S.H. Trp-Lys-Tyr-Met-Val-D-Met stimulates superoxide generation and killing of Staphylococcus aureus via phospholipase D activation in human monocytes. J. Leukoc. Biol. 1999, 65:241-248.
19. Berridge M.J. Inositol trisphosphate and calcium signaling. Nature 1993, 361:315-325.
20. Logan M.R., Odemuyiwa S.O., Moqbel R. Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. J. Allergy Clin. Immunol. 2003, 111:923-932.
21. Borregaard N. Neutrophils, from marrow to microbes. Immunity 2010, 33:657-670.
22. Kobayashi Y. The role of chemokines in neutrophil biology. Front. Biosci. 2008, 13:2400-2407.
23. Walther A., Riehemann K., Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 2000, 5:831-840.
24. Baggiolini M. Reflections on chemokines. Immunol. Rev. 2000, 177:5-7.
25. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu. Rev. Immunol. 1997, 15:675-705.
26. Cummings C.J., Martin T.R., Frevert C.W., Quan J.M., Wong V.A., Mongovin S.M., Hagen T.R., Steinberg K.P., Goodman R.B. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J. Immunol. 1999, 162:2341-2346.
27. Ness T.L., Hogaboam C.M., Strieter R.M., Kunkel S.L. Immunomodulatory role of CXCR2 during experimental septic peritonitis. J. Immunol. 2003, 171:3775-3784.
28. Kaneider N.C., Agarwal A., Leger A.J., Kuliopulos A. Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nat. Med. 2005, 11:661-665.